Sen. Widen convened local law enforcement, public health and treatment providers to review detection tools and early-warning systems for emerging synthetic opioids (referred to in the briefing with variant spellings such as “nitazines”/“nidazines”), hear data on current overdose contributors, and discuss a congressional funding request to expand local mass spectrometer coverage.